News

Filter

Current filters:

Activase

1 to 9 of 165 results

Actilyse approved to clear CVAD occlusion

09-06-2008

German drug major Boehringer Ingelheim has received the first approval for Actilyse (alteplase) 2mg within…

ActivaseAlteplaseBoehringer Ingelheim

Drug of benefit more than 3 hrs post stroke

03-03-2008

The results of a study of alteplase, the active component of Genentech's Activase, suggest that stroke…

ActivaseAlteplaseGenentech

Acute ischemic stroke market is "graveyard" for drug R&D

06-08-2007

A survey of R&D in the acute ischemic stroke market over the past decade has found that only one drug,...

ActivaseAlteplase

Boeh Ing's Actilyse gets nod from NICE

21-05-2007

German drugmaker Boehringer Ingelheim says that a new clinical appraisal published by the UK's National…

ActivaseAlteplaseBoehringer Ingelheim

SITS-MOST results confirm Actilyse's safety as a treatment for ischemic stroke

05-02-2007

German drugmaker Boehringer Ingelheim says that data from SITS-MOST (Safe Implementation of Thrombolysis…

ActivaseAlteplaseBoehringer Ingelheim

FibroGen's FG-4539 reduces brain tissue damage in ischemic stroke

27-02-2006

Florida, USA-based FibroGen has said that a single dose of FG-4539, its novel small-molecule inhibitor…

ActivaseAlteplase

CORRECTION: AstraZeneca's NXY-059 performs well in study

20-02-2006

CORRECTION: In the Friday 10th update to our web site, we incorrectlty stated that "the incidence of…

ActivaseAlteplaseAstraZeneca

1 to 9 of 165 results

COMPANY SPOTLIGHT

Menarini

Back to top